[go: up one dir, main page]

MX2018015216A - Nuevos derivados piperidinilo, un proceso para su preparacion y composiciones farmaceuticas que los contienen. - Google Patents

Nuevos derivados piperidinilo, un proceso para su preparacion y composiciones farmaceuticas que los contienen.

Info

Publication number
MX2018015216A
MX2018015216A MX2018015216A MX2018015216A MX2018015216A MX 2018015216 A MX2018015216 A MX 2018015216A MX 2018015216 A MX2018015216 A MX 2018015216A MX 2018015216 A MX2018015216 A MX 2018015216A MX 2018015216 A MX2018015216 A MX 2018015216A
Authority
MX
Mexico
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
piperidinyl derivatives
new piperidinyl
Prior art date
Application number
MX2018015216A
Other languages
English (en)
Other versions
MX374794B (es
Inventor
Geneste Olivier
Vasas Attila
Kotschy ANDRÁS
Brooke Murray James
Chanrion Maïa
Demarles Didier
Wéber Csaba
Molnár Balázs
Kiss Árpád
Macias Alba
Lewkowicz Elodie
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of MX2018015216A publication Critical patent/MX2018015216A/es
Publication of MX374794B publication Critical patent/MX374794B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Compuestos de fórmula (I): (Ver fórmula I) en la que R1, R2, R3, n y W son como se han definido en la descripción. Medicamentos.
MX2018015216A 2016-06-10 2017-06-09 Nuevos derivados piperidinilo, un proceso para su preparacion y composiciones farmaceuticas que los contienen MX374794B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1655392A FR3052452B1 (fr) 2016-06-10 2016-06-10 Nouveaux derives de piperidinyle, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/EP2017/064067 WO2017212012A1 (en) 2016-06-10 2017-06-09 New piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
MX2018015216A true MX2018015216A (es) 2019-04-25
MX374794B MX374794B (es) 2025-03-06

Family

ID=56943687

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018015216A MX374794B (es) 2016-06-10 2017-06-09 Nuevos derivados piperidinilo, un proceso para su preparacion y composiciones farmaceuticas que los contienen

Country Status (46)

Country Link
US (1) US11046681B2 (es)
EP (1) EP3468974B1 (es)
JP (1) JP6928005B2 (es)
KR (1) KR20190016106A (es)
CN (1) CN109311888B (es)
AR (1) AR108706A1 (es)
AU (1) AU2017277734B2 (es)
BR (1) BR112018075433A2 (es)
CA (1) CA3027014C (es)
CL (1) CL2018003474A1 (es)
CO (1) CO2018013210A2 (es)
CR (1) CR20180564A (es)
CU (1) CU20180145A7 (es)
CY (1) CY1122870T1 (es)
DK (1) DK3468974T3 (es)
DO (1) DOP2018000270A (es)
EA (1) EA037211B1 (es)
EC (1) ECSP18090144A (es)
ES (1) ES2775789T3 (es)
FR (1) FR3052452B1 (es)
GE (2) GEP20207160B (es)
HR (1) HRP20200361T1 (es)
HU (1) HUE049507T2 (es)
IL (1) IL263463B (es)
LT (1) LT3468974T (es)
MA (1) MA45222B1 (es)
MD (1) MD3468974T2 (es)
ME (1) ME03670B (es)
MX (1) MX374794B (es)
MY (1) MY196562A (es)
NI (1) NI201800132A (es)
NZ (1) NZ748946A (es)
PE (1) PE20220567A1 (es)
PH (1) PH12018502515B1 (es)
PL (1) PL3468974T3 (es)
PT (1) PT3468974T (es)
RS (1) RS60029B1 (es)
RU (1) RU2743163C2 (es)
SG (1) SG11201810629QA (es)
SI (1) SI3468974T1 (es)
SV (1) SV2018005791A (es)
TN (1) TN2018000410A1 (es)
TW (1) TWI620750B (es)
UA (1) UA123794C2 (es)
UY (1) UY37288A (es)
WO (1) WO2017212012A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109069488B (zh) 2016-03-07 2021-09-07 英安塔制药有限公司 乙型肝炎抗病毒剂
JP2020517618A (ja) 2017-04-21 2020-06-18 エピザイム,インコーポレイティド Ehmt2阻害剤との併用療法
EP3675637A4 (en) 2017-08-28 2021-05-19 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
US11332472B2 (en) * 2017-11-29 2022-05-17 Les Laboratoires Servier Substituted piperidines as inhibitors of ubiquitin specific protease 7
GB201801562D0 (en) * 2018-01-31 2018-03-14 Almac Diagnostics Ltd Pharmaceutical compounds
UY38291A (es) * 2018-07-05 2020-06-30 Servier Lab Nuevos derivados de amino-pirimidonilo un proceso para su preparación y composiciones farmacéuticas
MX2021003253A (es) 2018-09-21 2021-08-11 Enanta Pharm Inc Heterociclos funcionalizados como agentes antivirales.
UY38423A (es) * 2018-10-19 2021-02-26 Servier Lab Nuevos derivados amino-pirimidonil-piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen
SG11202105007TA (en) 2018-11-21 2021-06-29 Enanta Pharm Inc Functionalized heterocycles as antiviral agents
CN113365696A (zh) * 2018-12-06 2021-09-07 阿尔麦克探索有限公司 药物化合物和其作为泛素特异性蛋白酶19(usp19)抑制剂的用途
US11236111B2 (en) 2019-06-03 2022-02-01 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
US11760755B2 (en) 2019-06-04 2023-09-19 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
WO2020247575A1 (en) 2019-06-04 2020-12-10 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
WO2021007488A1 (en) 2019-07-11 2021-01-14 Enanta Pharmaceuticals, Inc. Substituted heterocycles as antiviral agents
US11236108B2 (en) 2019-09-17 2022-02-01 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
CN113087718B (zh) * 2020-01-09 2024-02-09 四川科伦博泰生物医药股份有限公司 噻吩并嘧啶酮类化合物及其医药应用
CN112608320B (zh) * 2020-01-16 2023-03-17 中国药科大学 哌啶类化合物及其制备方法和医药用途
GB202001980D0 (en) 2020-02-13 2020-04-01 Almac Discovery Ltd Therapeutic mentods
WO2021188414A1 (en) 2020-03-16 2021-09-23 Enanta Pharmaceuticals, Inc. Functionalized heterocyclic compounds as antiviral agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080081321A (ko) * 2005-12-21 2008-09-09 쉐링 코포레이션 H3 길항제/역 작용제 및 식욕 억제제의 조합물
CL2008000594A1 (es) * 2007-03-02 2008-09-05 Schering Corp Uso de compuestos derivados de heterociclos; composicion farmaceutica que comprende a dichos compuestos y otros agentes activos; y su uso para tratar diabetes, enfermedad arterial coronaria entre otras enfermedades.
EP2565186A1 (en) * 2011-09-02 2013-03-06 Hybrigenics S.A. Selective and reversible inhibitors of ubiquitin specific protease 7
AR103297A1 (es) * 2014-12-30 2017-05-03 Forma Therapeutics Inc Pirrolo y pirazolopirimidinas como inhibidores de la proteasa 7 específica de ubiquitina
SG11201810576QA (en) * 2016-06-10 2018-12-28 Servier Lab New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
TW201802092A (zh) 2018-01-16
EA201892838A1 (ru) 2019-06-28
LT3468974T (lt) 2020-04-10
MA45222B1 (fr) 2020-04-30
DK3468974T3 (da) 2020-05-11
RU2018147430A (ru) 2020-07-10
IL263463B (en) 2021-01-31
FR3052452B1 (fr) 2018-06-22
MD3468974T2 (ro) 2020-05-31
TN2018000410A1 (en) 2020-06-15
PH12018502515A1 (en) 2019-09-30
GEAP202014978A (en) 2020-06-10
DOP2018000270A (es) 2019-05-15
HRP20200361T1 (hr) 2020-06-12
SI3468974T1 (sl) 2020-07-31
CA3027014C (en) 2021-01-05
ECSP18090144A (es) 2019-01-31
TWI620750B (zh) 2018-04-11
MY196562A (en) 2023-04-19
HUE049507T2 (hu) 2020-09-28
ME03670B (en) 2020-10-20
UY37288A (es) 2018-01-02
CY1122870T1 (el) 2021-05-05
UA123794C2 (uk) 2021-06-02
EA037211B1 (ru) 2021-02-19
RU2018147430A3 (es) 2020-07-10
BR112018075433A2 (pt) 2019-03-19
GEP20207160B (en) 2020-10-12
NZ748946A (en) 2025-06-27
CO2018013210A2 (es) 2018-12-28
MX374794B (es) 2025-03-06
RU2743163C2 (ru) 2021-02-15
US20190144448A1 (en) 2019-05-16
US11046681B2 (en) 2021-06-29
CU20180145A7 (es) 2019-07-04
MA45222A (fr) 2019-04-17
CR20180564A (es) 2019-03-04
PL3468974T3 (pl) 2020-07-13
IL263463A (en) 2019-01-31
PT3468974T (pt) 2020-03-25
JP6928005B2 (ja) 2021-09-01
NI201800132A (es) 2019-04-08
ES2775789T3 (es) 2020-07-28
JP2019517556A (ja) 2019-06-24
CA3027014A1 (en) 2017-12-14
EP3468974B1 (en) 2020-02-12
WO2017212012A1 (en) 2017-12-14
CN109311888A (zh) 2019-02-05
CL2018003474A1 (es) 2019-05-24
RS60029B1 (sr) 2020-04-30
SV2018005791A (es) 2019-01-16
AU2017277734A1 (en) 2018-12-20
AU2017277734B2 (en) 2021-07-01
AR108706A1 (es) 2018-09-19
KR20190016106A (ko) 2019-02-15
PE20220567A1 (es) 2022-04-13
SG11201810629QA (en) 2018-12-28
FR3052452A1 (es) 2017-12-15
PH12018502515B1 (en) 2021-11-10
EP3468974A1 (en) 2019-04-17
CN109311888B (zh) 2021-09-14

Similar Documents

Publication Publication Date Title
MX2018015216A (es) Nuevos derivados piperidinilo, un proceso para su preparacion y composiciones farmaceuticas que los contienen.
MX2018015212A (es) Nuevos derivados piperidinilo sustituidos con hetero(arilo), un proceso para su preparacion y composiciones farmaceuticas que los contienen.
MX2017016995A (es) Nuevos derivados biciclicos, un proceso para su preparacion y composiciones farmaceuticas que los contienen.
NI201800076A (es) Nuevos derivados de amonio, un proceso para su preparación y composiciones farmacéuticas que los contienen
ECSP17082825A (es) Nuevos derivados hidroxiácido, un proceso para su preparación y composiciones farmacéuticas que los contienen
MX2017016997A (es) Nuevos derivados hidroxiester, un proceso para su preparacion y composiciones farmaceuticas que los contienen.
CR20170590A (es) Nuevos derivados hidroxiácido, un proceso para su preparación y composiciones farmacéuticas que los contienen
DOP2014000282A (es) Nuevos derivados tienopirimidina, un proceso para su preparacion y composiciones farmaceuticas que lo contienen
DOP2018000082A (es) NUEVOS DERIVADOS DE PIRROLO[2,3-d]PIRIMIDINA, UN PROCESO PARA SU PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN
DOP2018000083A (es) NUEVOS DERIVADOS DE IMIDAZO[4,5-b]PIRIDINA, UN PROCESO PARA SU PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN

Legal Events

Date Code Title Description
FG Grant or registration